Use of recombinant factor VIIa as a rescue treatment for intractable bleeding following repeat aortic arch repair.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 14667657.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Hemorrhage, refractory to aggressive conventional therapy, at a rate of 16 L/hr following separation from cardiopulmonary bypass for aortic arch repair, was controlled with a dose of 90 microg/kg of recombinant factor VIIa, repeated once after 2 hours.
Medical subject headings
- Aorta, Thoracic
- Factor VII
- Postoperative Hemorrhage
- Recombinant Proteins